Clinical Trial Detail

NCT ID NCT03317119
Title Trametinib and TAS-102 in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors City of Hope Medical Center
Indications

rectum cancer

colon cancer

Therapies

Trametinib + trifluridine/tipiracil hydrochloride

Age Groups: adult senior

Additional content available in CKB BOOST